Effentora

Effentora is a buccal film containing fentanyl citrate, used for managing breakthrough pain in adults already on opioid therapy. This fast-acting medication is designed for oral mucosal application.

Effentora is primarily used for the management of breakthrough pain in adults who are already receiving opioid therapy for chronic cancer pain. The buccal film is applied to the inner lining of the cheek, allowing for rapid absorption. It is important to note that Effentora is not intended for use in opioid-naive patients or for the treatment of acute or postoperative pain.

Effentora may cause common side effects such as nausea, dizziness, and headache. Some users may experience drowsiness or constipation. As with any medication, individual responses can vary, and it is important to monitor for any adverse reactions.

Effentora should be handled with care, ensuring it is stored safely and out of reach of children. It is crucial to follow the prescribed usage instructions to minimize the risk of side effects. Patients should avoid activities requiring mental alertness until they know how the medication affects them.

Effentora may interact with other medications, including central nervous system depressants like alcohol, benzodiazepines, and other opioids. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.